Watch Chris Baldwin, Deputy CEO of Exopharm (ASX:EX1), as he explains about the Exopharm’s latest developments and potential target markets. 0:00 – Intro 0:10 – What...
Watch Jon Pilcher, CEO of Neuren Pharmaceuticals (ASX:NEU), speaking about Neuren’s area of drug focus and the latest updates on the Trofinetide development. 0:11 – Firstly,...
Watch Chris Dunks, Executive Director of Elementos (ASX:ELT) explains about flagship Oropesa Tin Project and the recent surge on Tin prices. 0:00 – StockPal Introductions 0:10...
Watch Trevor Matthews, Managing Director of Volt Resources (ASX:VRC) explains about its business and its recent successful capital raise of AUD 3.65 million in February 2021....
Watch Bill Guy, Non-Executive Chairman of Theta Gold Mines (ASX:TGM | OTC:TGMGF) explains about its gold mines exploration plans in South Africa given their recent investment...
StockPal spoke to Neil McIntyre, Managing Director of Diatreme Resources (ASX:DRX) in this short Q&A interview. 0:13 – What is Diatreme Resources all about? 1:12 –...
Watch Dr. Mohammad Choucair, Chief Executive Officer of Archer Materials (ASX:AXE) explain about Archer’s latest patent approval in Japan for its quantum computing microchip and their...
